News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Cummings Keith Lamont
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 38,750 shares
@ $0 |
|
06/12/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Exercised 5,800 options to buy
@ $2.08, valued at
$12.1k
|
|
04/03/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Sold 9,960 shares
@ $26.5209, valued at
$264.1k
|
|
03/31/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 19,375 shares
@ $0 |
|
01/27/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 54,000 shares
@ $0 Granted 76,200 options to buy
@ $34.65, valued at
$2.6M
|
|
01/25/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Sold 30,000 shares
@ $35, valued at
$1.1M
Exercised 12,500 options to buy
@ $2.08, valued at
$26k
Exercised 17,500 options to buy
@ $6.22, valued at
$108.9k
|
|
12/21/2022 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 19,375 shares
@ $0 Sold 9,643 shares
@ $19.1024, valued at
$184.2k
|
|
02/02/2022 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 124,000 options to buy
@ $11.86, valued at
$1.5M
|
|
09/03/2021 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Exercised 20,000 options to buy
@ $2.08, valued at
$41.6k
|
|
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/23/2020 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Exercised 4,500 options to buy
@ $2.08, valued at
$9.4k
|
|
12/02/2020 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Sold 1,139 shares
@ $28.24, valued at
$32.2k
Sold 1,848 shares
@ $29.07, valued at
$53.7k
Sold 14,901 shares
@ $30.21, valued at
$450.2k
Sold 846 shares
@ $30.72, valued at
$26k
Exercised 11,591 options to buy
@ $2.08, valued at
$24.1k
Exercised 7,143 options to buy
@ $6.22, valued at
$44.4k
|
|
06/09/2020 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Exercised 19,300 shares
@ $2.08, valued at
$40.1k
Converted 3,821 shares
@ $0 Granted 27,322 preferred shares
@ $13.0845, valued at
$357.5k
Granted 42,841 options to buy
@ $0 Exercised 19,300 options to buy
@ $0 Converted 27,322 preferred shares
@ $0 |
|
06/02/2020 |
3
| Cummings Keith Lamont (CFO) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
|
|